Vildagliptin improves glucose sensitivity of cells in patients with type 2 diabetes: glucagon response to hypoglycemia

被引：0
|
作者：
Gautier, J. F.
Dejager, S. [1 ]
Foley, J. [2 ]
Halimi, S. [3 ]
Ahren, B. [4 ]
机构：
[1] Lab Novartis Pharma Sas, Rueil Malmaison, France
[2] Novartis, Clin Res, E Hanover, NJ USA
[3] CHU Grenoble, Serv Endocrinol Diabet Nutr, F-38043 Grenoble, France
[4] Lund Univ, Lund, Sweden
来源：
DIABETES & METABOLISM | 2009年 / 35卷
关键词：
D O I：
10.1016/S1262-3636(09)71722-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A8 / A8
页数：1
相关论文
共 50 条
  • [1] Vildagliptin improves alpha cell glucose sensing in patients with type 2 diabetes
    Ahren, B.
    Schweizer, A.
    Dejager, S.
    Dunning, B. E.
    Persson, M.
    Foley, J. E.
    DIABETOLOGIA, 2008, 51 : S36 - S37
  • [2] Vildagliptin suppresses prandial glucagon but enhances the glucagon response to hypoglycemia
    Ahren, Bo
    Schweizer, Anja
    Dejager, Sylvie
    Dunning, Beth E.
    Persson, Margaretha
    Foley, James E.
    DIABETES, 2008, 57 : A166 - A167
  • [3] Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes
    Farngren, Johan
    Persson, Margaretha
    Schweizer, Anja
    Foley, James E.
    Ahren, Bo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3799 - 3806
  • [4] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counter regulatory Response to Hypoglycemia in Type 1 Diabetes BB Rats
    Qin, Tairan
    Karimian, Negar
    Osundiji, Mayowa
    Huang, Yachi
    Coy, David H.
    Vranic, Mladen
    Gaisano, Herbert Y.
    DIABETES, 2012, 61 : A47 - A47
  • [5] Vildagliptin added to metformin improves glycacmic control by decreasing fasting and postprandial glucose in patients with type 2 diabetes
    Bosil, E.
    Collober, C.
    Rochotte, E.
    Camisasca, R. -P.
    Garber, A. J.
    DIABETOLOGIA, 2006, 49 : 480 - 481
  • [6] Vildagliptin added to sulfonylurea improves glycemic control without hypoglycemia and weight gain in Chinese patients with type 2 diabetes mellitus
    Yang, Wenying
    Xing, Xiaoping
    Lv, Xiaofeng
    Li, Yiming
    Ma, Jianhua
    Yuan, Guoyue
    Sun, Feifei
    Wang, Wei
    Woloschak, Michael
    Lukashevich, Valentina
    Kozlovski, Plamen
    Kothny, Wolfgang
    JOURNAL OF DIABETES, 2015, 7 (02) : 174 - 181
  • [7] Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes
    Israelian, Z
    Gosmanov, NR
    Szoke, E
    Schorr, M
    Bokhari, S
    Cryer, PE
    Gerich, JE
    Meyer, C
    DIABETES CARE, 2005, 28 (11) : 2691 - 2696
  • [8] Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes
    Ahren, Bo
    Schweizer, Anja
    Dejager, Sylvie
    Dunning, Beth E.
    Nilsson, Peter M.
    Persson, Margaretha
    Foley, James E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04): : 1236 - 1243
  • [9] Effect of Vildagliptin on Glucagon Concentration During Meals in Patients with Type 1 Diabetes
    Foley, J. E.
    Ligueros-Saylan, M.
    He, Y. -L
    Holst, J. J.
    Deacon, C. F.
    Dunning, B. E.
    Leone-Jones, A.
    Yu, T.
    Kelley, D. E.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (10) : 727 - 730
  • [10] Mechanisms by which vildagliptin reduces postprandial glucose excursions in patients with type 2 diabetes
    Woerle, Hans J.
    Lindenberger, Thilo
    Albrecht, Max
    Linke, Rainer
    Foley, James E.
    Ligueros-Saylan, Monica
    Sabo, Ron
    Zhang, Yiming
    He, Yan-Ling
    Beglinger, Christoph
    Goeke, Burkhard
    Schirra, Joerg
    DIABETES, 2008, 57 : A152 - A152
12345